&lt;i&gt;NR3C1&lt;/i&gt;, &lt;i&gt;LAX1&lt;/i&gt;, and &lt;i&gt;RCAN3&lt;/i&gt; as Circulating Epigenetic Biomarkers for Prognosis and Chemotherapy Response Prediction in Metastatic Pancreatic Cancer. This evidence concerns the gene NR3C1 and pancreatic neoplasm.